Is a complete TNGX research report available?

No complete published report is available for Tango Therapeutics, Inc. (TNGX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · USD

$22.2

-0.69 (-3.0%)· Recorded snapshot

Market cap	3.7B
Revenue (ttm)	53.8M
Net income (ttm)	-123.7M
EPS (ttm)	-$0.91
Shares out	168.6M
Volume	3,021,341
Beta	1.17

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.8M
Net income (ttm): -123.7M
EPS (ttm): -$0.91
Market cap: 3.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Metric	Value
Amount currency	USD
CIK code	0001819133
Company name	Tango Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	87583X109
Earnings date	2026-11-10
Earnings time	bmo
Employees	137
Employees change	-18
Employees growth	-11.61%
Enterprise value	$2.8B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US87583X1090
Last 10-K release date	2026-03-05
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.7B
Market cap category	Mid-Cap
Next earnings date	2026-11-10
Options	Yes
Price	$22.20
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	TNGX
U.S. state	Massachusetts
Website	https://www.tangotx.com

Metric

Value

Amount currency

USD

CIK code

0001819133

Company name

Tango Therapeutics, Inc.

Country

United States

Country code

CUSIP number

87583X109

Earnings date

2026-11-10

Earnings time

bmo

Employees

137

Employees change

-18

Employees growth

-11.61%

Enterprise value

$2.8B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US87583X1090

Last 10-K release date

2026-03-05

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.7B

Market cap category

Mid-Cap

Next earnings date

2026-11-10

Options

Yes

Price

$22.20

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

TNGX

U.S. state

Massachusetts

Website

https://www.tangotx.com

Metric	Value
Earnings yield	-4.12%
EV/Sales	55.06x
FCF / EV yield	-4.87%
FCF yield	-3.66%
Forward EV/Sales	1,312.56x
Forward P/S	1,747.63x
P/B ratio	3.76x
P/S ratio	73.31x
Price / tangible book value	3.85x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-4.12%

EV/Sales

55.06x

FCF / EV yield

-4.87%

FCF yield

-3.66%

Forward EV/Sales

1,312.56x

Forward P/S

1,747.63x

P/B ratio

3.76x

P/S ratio

73.31x

Price / tangible book value

3.85x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-253.38%
EBITDA margin	-249.81%
Gross margin	-148.37%
Operating margin	-253.38%
Pretax margin	-230.03%
Profit margin	-229.92%
Profit per employee	$-903,073
Revenue per employee	$392,781
ROA	-12.99%
ROA (5Y)	-17.38%
ROCE	-12.94%
ROE	-21.34%
ROE (5Y)	-40.42%
ROIC	-13.9%
SBC / revenue	74.88%
Tax / revenue	-0.12%

Metric

Value

EBIT margin

-253.38%

EBITDA margin

-249.81%

Gross margin

-148.37%

Operating margin

-253.38%

Pretax margin

-230.03%

Profit margin

-229.92%

Profit per employee

$-903,073

Revenue per employee

$392,781

ROA

-12.99%

ROA (5Y)

-17.38%

ROCE

-12.94%

ROE

-21.34%

ROE (5Y)

-40.42%

ROIC

-13.9%

SBC / revenue

74.88%

Tax / revenue

-0.12%

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	121.48%
Revenue growth 3Y	16.89%
Revenue growth 5Y	19.14%
Revenue growth years	3

Metric

Value

EPS growth years

Net income growth years

Revenue growth

121.48%

Revenue growth 3Y

16.89%

Revenue growth 5Y

19.14%

Revenue growth years

Metric	Value
Capital expenditures	$-373,000
Depreciation and amortization	$1.9M
EBIT	$-136.3M
EBITDA	$-134.4M
EPS	$-0.91
FCF per share	$-0.86
Financing cash flow	$974.3M
Free cash flow	$-144.3M
Free cash flow minus SBC	$-184.6M
Gross profit	$-79.8M
Income taxes	$-63,000
Investing cash flow	$-524.6M
Net cash flow	$305.9M
Net income	$-123.7M
Operating cash flow minus SBC	$-184.2M
Operating income	$-136.3M
Revenue	$53.8M
Stock-based compensation	$40.3M

Metric

Value

Capital expenditures

$-373,000

Depreciation and amortization

$1.9M

EBIT

$-136.3M

EBITDA

$-134.4M

EPS

$-0.91

FCF per share

$-0.86

Financing cash flow

$974.3M

Free cash flow

$-144.3M

Free cash flow minus SBC

$-184.6M

Gross profit

$-79.8M

Income taxes

$-63,000

Investing cash flow

$-524.6M

Net cash flow

$305.9M

Net income

$-123.7M

Operating cash flow minus SBC

$-184.2M

Operating income

$-136.3M

Revenue

$53.8M

Stock-based compensation

$40.3M

Metric	Value
Altman Z-Score	21.98
Book value per share	$6.08
Debt / equity	0.03
Long-term assets	$42.2M
Long-term liabilities	$29M
Net cash (debt)	$982M
Net cash / market cap	24.89%
Net cash growth	573.63%
Net debt / equity	-0.96
Piotroski F-Score	3
Property, plant and equipment	$39.8M
Shareholders' equity	$1B
Tangible book value	$1B
Tangible book value per share	$6.08
Total assets	$1.1B
Total cash	$1B
Total debt	$32M
Total liabilities	$49.3M
WACC	10.6%

Metric

Value

Altman Z-Score

21.98

Book value per share

$6.08

Debt / equity

0.03

Long-term assets

$42.2M

Long-term liabilities

$29M

Net cash (debt)

$982M

Net cash / market cap

24.89%

Net cash growth

573.63%

Net debt / equity

-0.96

Piotroski F-Score

Property, plant and equipment

$39.8M

Shareholders' equity

$1B

Tangible book value

$1B

Tangible book value per share

$6.08

Total assets

$1.1B

Total cash

$1B

Total debt

$32M

Total liabilities

$49.3M

WACC

10.6%

Metric	Value
Asset turnover	0.08
Current assets	$1B
Current liabilities	$20.3M
Current ratio	50.82
Net working capital	$325,000
Quick ratio	49.95
Working capital	$1B
Working capital turnover	0.09

Metric

Value

Asset turnover

0.08

Current assets

$1B

Current liabilities

$20.3M

Current ratio

50.82

Net working capital

$325,000

Quick ratio

49.95

Working capital

$1B

Working capital turnover

0.09

Metric	Value
Buyback yield / dilution	-22.81%
Dividend yield	0%
Shareholder yield	-22.81%

Metric

Value

Buyback yield / dilution

-22.81%

Dividend yield

Shareholder yield

-22.81%

Metric	Value
150-day SMA	$24.98
1D price change	-3.01%
1M price change	-9.19%
1M total return	-9.19%
1W price change	-10.38%
1W total return	-10.38%
1Y price change	191.25%
1Y return CAGR	191.46%
1Y total return	191.25%
20-day SMA	$23.45
200-day SMA	$22.22
3M price change	-15.31%
3M total return	-15.31%
3Y price change	182.52%
3Y return CAGR	41.36%
3Y total return	182.52%
50-day SMA	$23.68
50-day SMA vs 200-day SMA	50over200
52-week high	$34.39
52-week high date	2026-06-17
52-week low	$7.37
52-week low date	2025-11-07
5Y price change	82.5%
5Y return CAGR	12.79%
5Y total return	82.5%
6M price change	-14.05%
6M total return	-14.05%
All-time high	$34.39
All-time high date	2026-06-17
All-time low	$1.03
All-time low date	2025-05-08
Average true range (ATR)	$1.86
Average volume	4.5M
Beta (1Y)	0.63
Beta (2Y)	1.21
Beta (5Y)	1.17
Change from 52-week high	-35.45%
Change from 52-week low	201.22%
Change from all-time high	-34.2%
Change from all-time low	2,097.09%
Change from open	-2.25%
Day's gap	-0.79%
Dollar volume	$67.1M
High price	$23.68
Low price	$22.19
Monthly RSI	61.61
Open price	$22.71
Position in 52-week range	0.67%
Premarket change	-0.61%
Premarket close	$22.89
Premarket price	$22.75
Premarket volume	11.5K
Previous close	$22.89
Price vs 150-day SMA	-9.4%
Price vs 20-day SMA	-3.48%
Price vs 200-day SMA	1.85%
Price vs 50-day SMA	-4.44%
Relative volume	0.66
RSI	46
Sharpe ratio	1.48
Sharpe ratio (3Y)	0.82
Sharpe ratio (5Y)	0.53
Sortino ratio	2.95
Sortino ratio (3Y)	1.47
Sortino ratio (5Y)	1.01
Volume	3M
Weekly RSI	50.07
YTD price change	155.42%
YTD total return	155.42%

Metric

Value

150-day SMA

$24.98

1D price change

-3.01%

1M price change

-9.19%

1M total return

-9.19%

1W price change

-10.38%

1W total return

-10.38%

1Y price change

191.25%

1Y return CAGR

191.46%

1Y total return

191.25%

20-day SMA

$23.45

200-day SMA

$22.22

3M price change

-15.31%

3M total return

-15.31%

3Y price change

182.52%

3Y return CAGR

41.36%

3Y total return

182.52%

50-day SMA

$23.68

50-day SMA vs 200-day SMA

50over200

52-week high

$34.39

52-week high date

2026-06-17

52-week low

$7.37

52-week low date

2025-11-07

5Y price change

82.5%

5Y return CAGR

12.79%

5Y total return

82.5%

6M price change

-14.05%

6M total return

-14.05%

All-time high

$34.39

All-time high date

2026-06-17

All-time low

$1.03

All-time low date

2025-05-08

Average true range (ATR)

$1.86

Average volume

4.5M

Beta (1Y)

0.63

Beta (2Y)

1.21

Beta (5Y)

1.17

Change from 52-week high

-35.45%

Change from 52-week low

201.22%

Change from all-time high

-34.2%

Change from all-time low

2,097.09%

Change from open

-2.25%

Day's gap

-0.79%

Dollar volume

$67.1M

High price

$23.68

Low price

$22.19

Monthly RSI

61.61

Open price

$22.71

Position in 52-week range

0.67%

Premarket change

-0.61%

Premarket close

$22.89

Premarket price

$22.75

Premarket volume

11.5K

Previous close

$22.89

Price vs 150-day SMA

-9.4%

Price vs 20-day SMA

-3.48%

Price vs 200-day SMA

1.85%

Price vs 50-day SMA

-4.44%

Relative volume

0.66

RSI

Sharpe ratio

1.48

Sharpe ratio (3Y)

0.82

Sharpe ratio (5Y)

0.53

Sortino ratio

2.95

Sortino ratio (3Y)

1.47

Sortino ratio (5Y)

1.01

Volume

Weekly RSI

50.07

YTD price change

155.42%

YTD total return

155.42%

Metric	Value
Float	120.7M
Float percentage	71.57%
Shares change (QoQ)	4.39%
Shares change (YoY)	22.81%
Shares held by insiders	1.07%
Shares held by institutions	100.89%
Shares outstanding	168.6M
Short % of float	36.88%
Short % of shares	26.39%
Short ratio	15.2 days

Metric

Value

Float

120.7M

Float percentage

71.57%

Shares change (QoQ)

4.39%

Shares change (YoY)

22.81%

Shares held by insiders

1.07%

Shares held by institutions

100.89%

Shares outstanding

168.6M

Short % of float

36.88%

Short % of shares

26.39%

Short ratio

15.2 days

Tango Therapeutics, Inc. (TNGX)

Price

Financial snapshot

Fair-value bridge

Latest news · TNGX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNGX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TNGX

Frequently asked questions